Why the study?
Ergometrine can occasionally precipitate myocardial ischemia during treatment for postpartum hemorrhage in the setting of significant anemia without preexisting cardiac risk factors.
Ergometrine used for postpartum hemorrhage can precipitate myocardial ischemia, especially in patients with significant anemia, requiring prompt recognition and treatment.
May warrant monitoring for ischemia with ergometrine in anemic postpartum patients; leaves open the need for prospective risk studies.
Ergometrine is recommended for use in the medical treatment of postpartum hemorrhage. Ergometrine can occasionally precipitate myocardial ischemia in the setting of significant anemia in women without preexisting cardiac risk factors, and it is important to recognize and treat myocardial ischemia in affected patients to prevent severe complications.
No takes yet. Share an insight, caveat, or question.
Spencer et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: